Here is the detailed overview of Buprenorphine (A) + Naloxone (B) Sublingual Tablet 0.4 mg + 0.1 mg, with icons:
💊 Buprenorphine + Naloxone Sublingual Tablet
Dose: 0.4 mg (A) + 0.1 mg (B)
Route: 👅 Sublingual (under the tongue)
🧪 Nature / Drug Class
🔹 Buprenorphine – Partial opioid agonist
🔹 Naloxone – Opioid antagonist
🔹 Combination used for opioid substitution therapy
🔹 Designed to discourage misuse via injection
🩺 Purpose / Indications
✅ Used in:
- 🔄 Opioid dependence treatment
- 🚭 Maintenance therapy during opioid withdrawal
- 🧠 Part of de-addiction and rehabilitation programs
🔐 Naloxone has low sublingual absorption but blocks effects if misused via injection – deters abuse.
⚙️ Advantages
✔️ Helps reduce cravings and withdrawal symptoms
✔️ Lowers risk of relapse and overdose
✔️ Safer than methadone in many cases
✔️ Naloxone component reduces misuse potential
✔️ Long duration of action
📦 Common Packaging
📦 Blister strips of sublingual tablets
📄 Available in various strengths (e.g., 2/0.5 mg, 4/1 mg in other regimens)
⚖️ 0.4 mg/0.1 mg is often used in initiation or dose titration phase
⚠️ Patient Advice / Precautions
👅 Do not chew or swallow – allow to dissolve under tongue
🚫 Avoid alcohol or sedatives – may increase drowsiness
🕐 Take doses as prescribed, preferably same time daily
🧾 Must be used under medical supervision
📋 May require counseling support during therapy
🚫 Do not inject – naloxone will block opioid effect and may precipitate withdrawal
🚫 Contraindications / Cautions
❌ Allergy to buprenorphine or naloxone
❌ Severe respiratory depression
⚠️ Use cautiously in:
- Liver disease
- Pregnant/breastfeeding women
- CNS depression or head injury
🧊 Storage
🌡️ Store at room temperature (15–30°C)
🔒 Keep in a secure place – potential for misuse
🧒 Keep away from children